Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125426211 | 12542621 | 1 | I | 2014 | 20160613 | 20160709 | 20160709 | PER | US-JNJFOC-20160613835 | JANSSEN | 0.00 | M | Y | 0.00000 | 20160709 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125426211 | 12542621 | 1 | PS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | 22264 | 234 | MG | INJECTION | |||||||
| 125426211 | 12542621 | 2 | SS | INVEGA TRINZA | PALIPERIDONE PALMITATE | 1 | Intramuscular | U | 207946 | 819 | MG | SUSPENSION FOR INJECTION | |||||||
| 125426211 | 12542621 | 3 | SS | METHAMPHETAMINE | METHAMPHETAMINE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 125426211 | 12542621 | 4 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125426211 | 12542621 | 5 | C | ATIVAN | LORAZEPAM | 1 | Oral | 0 | UNKNOWN | ||||||||||
| 125426211 | 12542621 | 6 | C | VISTARIL | HYDROXYZINE PAMOATE | 1 | Oral | 0 | UNKNOWN | ||||||||||
| 125426211 | 12542621 | 7 | C | KLONOPIN | CLONAZEPAM | 1 | Oral | 0 | UNKNOWN | ||||||||||
| 125426211 | 12542621 | 8 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125426211 | 12542621 | 1 | Bipolar I disorder |
| 125426211 | 12542621 | 2 | Bipolar I disorder |
| 125426211 | 12542621 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125426211 | 12542621 | Akathisia | |
| 125426211 | 12542621 | Off label use | |
| 125426211 | 12542621 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125426211 | 12542621 | 1 | 20141103 | 2016 | 0 | |
| 125426211 | 12542621 | 2 | 2016 | 20160606 | 0 |